Attempts to express eukaryotic multi-spanning membrane proteins at high-levels have been generally unsuccessful. In order to investigate the cause of this limitation and gain insight into the rate limiting processes involved, we have analyzed the effect of translation levels on the expression of several human membrane proteins in Escherichia coli (E. coli). These results demonstrate that excessive translation initiation rates of membrane proteins cause a block in protein synthesis and ultimately prevent the high-level accumulation of these proteins. Moderate translation rates allow coupling of peptide synthesis and membrane targeting, resulting in a significant increase in protein expression and accumulation over time. The current study evaluates four membrane proteins, CD20 (4-transmembrane (TM) helixes), the G-protein coupled receptors (GPCRs, 7-TMs) RA1c and EG-VEGFR1, and Patched 1 (12-TMs), and demonstrates the critical role of translation initiation rates in the targeting, insertion and folding of integral membrane proteins in the E. coli membrane.
References
[1]
Egea PF, Stroud RM, Walter P (2005) Targeting proteins to membranes: structure of the signal recognition particle. Curr Opin Struct Biol 15: 213–220.
[2]
Luirink J, von Heijne G, Houben E, de Gier JW (2005) Biogenesis of inner membrane proteins in Escherichia coli. Annu Rev Microbiol 59: 329–355.
[3]
Hessa T, Kim H, Bihlmaier K, Lundin C, Boekel J, et al. (2005) Recognition of transmembrane helices by the endoplasmic reticulum translocon. Nature 433: 377–381.
[4]
Powers T, Walter P (1997) Co-translational protein targeting catalyzed by the Escherichia coli signal recognition particle and its receptor. Embo J 16: 4880–4886.
[5]
Walter P, Blobel G (1983) Subcellular distribution of signal recognition particle and 7SL-RNA determined with polypeptide-specific antibodies and complementary DNA probe. J Cell Biol 97: 1693–1699.
[6]
Mason N, Ciufo LF, Brown JD (2000) Elongation arrest is a physiologically important function of signal recognition particle. Embo J 19: 4164–4174.
[7]
Siegel V, Walter P (1986) Removal of the Alu structural domain from signal recognition particle leaves its protein translocation activity intact. Nature 320: 81–84.
[8]
Wagner S, Baars L, Ytterberg AJ, Klussmeier A, Wagner CS, et al. (2007) Consequences of membrane protein overexpression in Escherichia coli. Mol Cell Proteomics 6: 1527–1550.
[9]
Sarkar CA, Dodevski I, Kenig M, Dudli S, Mohr A, et al. (2008) Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity. Proc Natl Acad Sci U S A 105: 14808–14813.
[10]
van Dalen A, Schrempf H, Killian JA, de Kruijff B (2000) Efficient membrane assembly of the KcsA potassium channel in Escherichia coli requires the protonmotive force. EMBO Rep 1: 340–346.
[11]
Shand RF, Miercke LJ, Mitra AK, Fong SK, Stroud RM, et al. (1991) Wild-type and mutant bacterioopsins D85N, D96N, and R82Q: high-level expression in Escherichia coli. Biochemistry 30: 3082–3088.
[12]
Miroux B, Walker JE (1996) Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol 260: 289–298.
[13]
Wagner S, Klepsch MM, Schlegel S, Appel A, Draheim R, et al. (2008) Tuning Escherichia coli for membrane protein overexpression. Proc Natl Acad Sci U S A 105: 14371–14376.
[14]
Wagner S, Bader ML, Drew D, de Gier JW (2006) Rationalizing membrane protein overexpression. Trends Biotechnol 24: 364–371.
[15]
Ernst JA, Li H, Kim HS, Nakamura GR, Yansura DG, et al. (2005) Isolation and characterization of the B-cell marker CD20. Biochemistry 44: 15150–15158.
[16]
Weng J, Ma W, Mitchell D, Zhang J, Liu M (2005) Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors. J Cell Biochem 96: 1034–1048.
[17]
Xu LL, Stackhouse BG, Florence K, Zhang W, Shanmugam N, et al. (2000) PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res 60: 6568–6572.
[18]
Parker R, Liu M, Eyre HJ, Copeland NG, Gilbert DJ, et al. (2000) Y-receptor-like genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6. Biochim Biophys Acta 1491: 369–375.
[19]
Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, et al. (2002) Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 277: 19276–19280.
[20]
Battersby S, Critchley HO, Morgan K, Millar RP, Jabbour HN (2004) Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle. J Clin Endocrinol Metab 89: 2463–2469.
[21]
Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, et al. (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272: 1668–1671.
[22]
Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, et al. (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85: 841–851.
[23]
Studier FW, Moffatt BA (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189: 113–130.
[24]
de Boer HA, Comstock LJ, Vasser M (1983) The tac promoter: a functional hybrid derived from the trp and lac promoters. Proc Natl Acad Sci U S A 80: 21–25.
[25]
Kikuchi Y, Yoda K, Yamasaki M, Tamura G (1981) The nucleotide sequence of the promoter and the amino-terminal region of alkaline phosphatase structural gene (phoA) of Escherichia coli. Nucleic Acids Res 9: 5671–5678.
[26]
Makino K, Shinagawa H, Amemura M, Nakata A (1986) Nucleotide sequence of the phoB gene, the positive regulatory gene for the phosphate regulon of Escherichia coli K-12. J Mol Biol 190: 37–44.
[27]
Scholtissek S, Grosse F (1987) A cloning cartridge of lambda t(o) terminator. Nucleic Acids Res 15: 3185.
[28]
Miozzari GF, Yanofsky C (1978) Translation of the leader region of the Escherichia coli tryptophan operon. J Bacteriol 133: 1457–1466.
[29]
McCarthy JE, Gualerzi C (1990) Translational control of prokaryotic gene expression. Trends Genet 6: 78–85.
[30]
Ishidate K, Creeger ES, Zrike J, Deb S, Glauner B, et al. (1986) Isolation of differentiated membrane domains from Escherichia coli and Salmonella typhimurium, including a fraction containing attachment sites between the inner and outer membranes and the murein skeleton of the cell envelope. J Biol Chem 261: 428–443.
[31]
Hayhurst A, Harris WJ (1999) Escherichia coli skp chaperone coexpression improves solubility and phage display of single-chain antibody fragments. Protein Expr Purif 15: 336–343.
[32]
Berinstein NL, Grillo-Lopez AJ, White CA, Bence-Bruckler I, Maloney D, et al. (1998) Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol 9: 995–1001.
[33]
Polyak MJ, Deans JP (2002) Alanine-170 and proline-172 are critical determinants for extracellular CD20 epitopes; heterogeneity in the fine specificity of CD20 monoclonal antibodies is defined by additional requirements imposed by both amino acid sequence and quaternary structure. Blood 99: 3256–3262.
[34]
Columbus L, Lipfert J, Jambunathan K, Fox DA, Sim AY, et al. (2009) Mixing and matching detergents for membrane protein NMR structure determination. J Am Chem Soc 131: 7320–7326.
[35]
Eshaghi S, Hedren M, Nasser MI, Hammarberg T, Thornell A, et al. (2005) An efficient strategy for high-throughput expression screening of recombinant integral membrane proteins. Protein Sci 14: 676–683.
[36]
Newstead S, Kim H, von Heijne G, Iwata S, Drew D (2007) High-throughput fluorescent-based optimization of eukaryotic membrane protein overexpression and purification in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 104: 13936–13941.
[37]
Ren H, Yu D, Ge B, Cook B, Xu Z, et al. (2009) High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1. PLoS One 4: e4509.
[38]
Jensen PR, Westerhoff HV, Michelsen O (1993) The use of lac-type promoters in control analysis. Eur J Biochem 211: 181–191.
[39]
Simmons LC, Reilly D, Klimowski L, Raju TS, Meng G, et al. (2002) Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J Immunol Methods 263: 133–147.
